Cited 0 times in
Metformin treatment is associated with improved survival in diabetic patients hospitalized with acute heart failure: A prospective observational study using the Korean acute heart failure registry data
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 강석민 | - |
dc.contributor.author | 오재원 | - |
dc.contributor.author | 이찬주 | - |
dc.date.accessioned | 2024-03-22T06:38:32Z | - |
dc.date.available | 2024-03-22T06:38:32Z | - |
dc.date.issued | 2024-01 | - |
dc.identifier.issn | 1262-3636 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/198580 | - |
dc.description.abstract | Aims Although the hypothesis that metformin is beneficial for patients with diabetes and heart failure (HF) has been steadily raised, there is limited data on metformin use in patients with acute HF. We analyzed the association of metformin on all-cause mortality in hospitalized patients with type 2 diabetes and acute HF. Methods The Korean Acute Heart Failure registry prospectively enrolled patients hospitalized for acute HF from 2011 to 2014. Among this cohort, we analyzed patients with diabetes with baseline estimated glomerular filtration rate (eGFR) of 30 ml/min/1.73 m2 or more. We analyzed the all-cause mortality and re-hospitalization for HF within 1 year after discharge. Inverse probability treatment weighting method was used to adjust baseline differences on metformin treatment. Results The study analyzed data from 1,309 patients with HF and diabetes (mean age 69 years, 56 % male). Among them, 613 (47 %) patients were on metformin at admission. During the median follow-up period of 11 months, 132 (19 %) and 74 (12 %) patients not receiving and receiving metformin treatment died, respectively. The mortality rate was lower in metformin users than in non-users (hazard ratio 0.616 [0.464–0.819] P<0.001). After adjustment, metformin was significantly associated with a lower risk for the mortality (hazard ratio 0.677 [0.495–0.928] P=0.015). In subgroup analyses, this association remains significant irrespective of baseline kidney function (eGFR <60 or ≥60 ml/min/1.73 m2, P-for-interaction=0.176) or left ventricular ejection fraction (<40 %, 40–49 %, or ≥50 %, P-for-interaction=0.224). Conclusions Metformin treatment at the time of admission was associated with a lower risk for 1-year mortality in patients with diabetes, hospitalized for acute HF. | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English, French | - |
dc.publisher | Masson | - |
dc.relation.isPartOf | DIABETES & METABOLISM | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | Aged | - |
dc.subject.MESH | Diabetes Mellitus, Type 2* / complications | - |
dc.subject.MESH | Diabetes Mellitus, Type 2* / drug therapy | - |
dc.subject.MESH | Diabetes Mellitus, Type 2* / epidemiology | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Heart Failure* / drug therapy | - |
dc.subject.MESH | Heart Failure* / epidemiology | - |
dc.subject.MESH | Heart Failure* / etiology | - |
dc.subject.MESH | Hospitalization | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Metformin* / therapeutic use | - |
dc.subject.MESH | Prospective Studies | - |
dc.subject.MESH | Republic of Korea / epidemiology | - |
dc.subject.MESH | Routinely Collected Health Data | - |
dc.subject.MESH | Stroke Volume | - |
dc.subject.MESH | Ventricular Function, Left | - |
dc.title | Metformin treatment is associated with improved survival in diabetic patients hospitalized with acute heart failure: A prospective observational study using the Korean acute heart failure registry data | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Kyeong-Hyeon Chun | - |
dc.contributor.googleauthor | Jaewon Oh | - |
dc.contributor.googleauthor | Chan Joo Lee | - |
dc.contributor.googleauthor | Jin Joo Park | - |
dc.contributor.googleauthor | Sang Eun Lee | - |
dc.contributor.googleauthor | Min-Seok Kim | - |
dc.contributor.googleauthor | Hyun-Jai Cho | - |
dc.contributor.googleauthor | Jin-Oh Choi | - |
dc.contributor.googleauthor | Hae-Young Lee | - |
dc.contributor.googleauthor | Kyung-Kuk Hwang | - |
dc.contributor.googleauthor | Kye Hun Kim | - |
dc.contributor.googleauthor | Byung-Su Yoo | - |
dc.contributor.googleauthor | Dong-Ju Choi | - |
dc.contributor.googleauthor | Sang Hong Baek | - |
dc.contributor.googleauthor | Eun-Seok Jeon | - |
dc.contributor.googleauthor | Jae-Joong Kim | - |
dc.contributor.googleauthor | Myeong-Chan Cho | - |
dc.contributor.googleauthor | Shung Chull Chae | - |
dc.contributor.googleauthor | Byung-Hee Oh | - |
dc.contributor.googleauthor | Seok-Min Kang | - |
dc.identifier.doi | 10.1016/j.diabet.2023.101504 | - |
dc.contributor.localId | A00037 | - |
dc.contributor.localId | A02395 | - |
dc.contributor.localId | A03238 | - |
dc.relation.journalcode | J00719 | - |
dc.identifier.eissn | 1878-1780 | - |
dc.identifier.pmid | 38097010 | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S1262363623000861 | - |
dc.subject.keyword | Acute heart failure | - |
dc.subject.keyword | Mortality, Metformin | - |
dc.subject.keyword | Type 2 diabetes | - |
dc.contributor.alternativeName | Kang, Seok Min | - |
dc.contributor.affiliatedAuthor | 강석민 | - |
dc.contributor.affiliatedAuthor | 오재원 | - |
dc.contributor.affiliatedAuthor | 이찬주 | - |
dc.citation.volume | 50 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 101504 | - |
dc.identifier.bibliographicCitation | DIABETES & METABOLISM, Vol.50(1) : 101504, 2024-01 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.